A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age
Clinical trial NCT07300839 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07300839
- Sponsor
- BioNTech SE
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-10
- Primary completion
- 2026-07-31
- Enrollment
- 5240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.